Dr Reddy’s Laboratories has secured European Commission approval for AVT03, its biosimilar of Prolia and Xgeva used in treating osteoporosis and bone-related conditions. Developed by Alvotech, the product will be commercialised by Dr Reddy’s across the US, Europe, and other market
Association of Indian Medical Device Industry says changing GST rates for medical devices could impact domestic competitiveness if not carefully managed
The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants
Hyderabad: The Sistema Group company, Binnopharm Group, signed an agreement with Dr Reddy’s Laboratories to acquire anti-bacterial medicines under the Ciprolet and Levolet brands from Dr Reddy’s in Russia, Uzbekistan, and Belarus. The portfolio includes various dosage forms such as tablets, solution for infusions and eye drops. Rustem Muratov, CEO of the Binnopharm Group said, […]
Hyderabad: Dr Reddy’s is strengthening its Covid portfolio with a range of drugs and vaccine options. The company is in various stages of regulatory clearances for Sputnik Light and Sputnik V booster dose. Phase III clinical trial data of Sputnik Light has been submitted to the Indian regulator. Additional data from clinical trials for Sputnik […]
Hyderabad: Dr Reddy’s Laboratories said on Tuesday the company will launch its molnupiravir capsules 200mg under its brand name Molflu across India. The drug will be priced at Rs 35 per capsule with 10 capsules contained per strip, and the total course of 40 capsules over five days costing Rs 1,400. Molflu is expected to […]
Hyderabad: The much-awaited first oral medication for Covid-19 based on Molnupiravir is expected to hit the shelves of drug stores in the coming months. While the oral pill has received lot of attention for its therapeutic promise in reducing hospital stay and death risk among Covid patients, the fact remains that Hyderabad, due to its […]
Hyderabad: Hyderabad-based pharmaceutical company Dr Reddy’s on Friday said it hopes to submit phase 3 trial data of Sputnik V Light, the single dose vaccine, to the Drugs Controller General of India (DCGI) next month. The company is also starting trials on children in two cohorts involving children of the age groups of 2-12 years […]
